Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Japer Therapeutics, Inc. Warrants (JSPRW)

Biological Products, (no Disgnostic Substances)

https://www.jaspertherapeutics.com

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

2200 BRIDGE PKWY SUITE #102
REDWOOD CITY, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/27/2021

Market Cap

258,967,938

Shares Outstanding

110,850,000

Weighted SO

N/A

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

ROIVW --.--%

SABSW --.--%

NRXPW --.--%

CELUW --.--%

EFTRW --.--%

Beta

2.2200

Last Div

0.0000

Range

0.2005-0.2005

Chg

-0.0095

Avg Vol

N/A

Mkt Cap

258967938

Exch

NASDAQ

Country

US

Phone

650 549 1400

DCF Diff

10.2714

DCF

8.0564

Div Yield

0.0000

P/S

0.0000

EV Multiple

-2.5321

P/FV

2731.7887

Div Yield %

0.0000

P/E

-5726.4063

PEG

-843.6905

Payout

0.0000

Current Ratio

10.7946

Quick Ratio

10.7946

Cash Ratio

10.6098

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

1277.2845

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

-0.0094

ROA

-0.4200

ROE

-0.4957

ROCE

-0.6562

NI/EBT

1.0000

EBT/EBIT

0.7022

EBIT/Rev

0.0000

Debt Ratio

0.0203

D/E

0.0231

LT Debt/Cap

0.0127

Total Debt/Cap

0.0226

Int Coverage

217.7380

CF/Debt

-19.0829

Equity Multi

1.1358

Rec Turnover

0.0000

Pay Turnover

0.2858

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-0.0029

FCF/Share

-0.0030

Cash/Share

0.0071

OCF/Sales

0.0000

FCF/OCF

1.0058

CF Coverage

-19.0829

ST Coverage

-42.9504

CapEx Coverage

-173.3176

Div&CapEx Cov

-173.3176

P/BV

2731.7887

P/B

2731.7887

P/S

0.0000

P/E

-5726.4063

P/FCF

-6.2055

P/OCF

-6200.2380

P/CF

-6200.2380

PEG

-843.6905

P/S

0.0000

EV Multiple

-2.5321

P/FV

2731.7887

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jun 14, 14:00 Jasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria GlobeNewswire Inc. Mar 01, 17:45 Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

Revenue Product Segmentation